在四名青少年中,在急性素过量服用后发生了普遍性发作
Matthew K Kolbeck1, Rachel F Schult2, Nicholas Nacca2
1SUNY Upstate Medical University, Syracuse, NY, USA; Upstate New York Poison Center, Syracuse, NY, USA.
The American journal of emergency medicine
|November 13, 2023
概括
急性西过量服用可能导致发作,即使剂量低于之前报告的剂量. 这项研究强调了发作是青少年在大量摄入素后被低估的并发症.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 儿科急救医学 儿科急救医学
背景情况:
- 作为一种选择性血清素再吸收抑制剂的西,通常被认为与其他精神药物相比,在过量服用时严重毒性的风险较低.
- 普遍性发作是一种罕见但已有记录的急性素过量剂的并发症,通常发生在摄入≥1000毫克后,摄入后1-16小时之间.
研究的目的:
- 报告一系列的青少年病例经历了急性西过量后的发作.
- 为了研究可能低于先前确定的值剂量的发作发生情况.
主要方法:
- 回顾四名青少年的病例系列,在急性素过量服用后出现发作.
- 进行了剂量计算 (mg/kg) 和评估血清毒性症状.
- 记录了儿科急诊室的临床过程和管理.
主要成果:
- 四名青少年在摄入600-1200毫克 (10-19.5毫克/公斤) 西后,在摄入后3-9小时之间经历了普遍性发作.
- 患者表现出轻度的血清激素过量,满足了血清激素毒性的两个标准.
- 没有患者有复发性发作或进一步的并发症;没有人需要神经影像或神经学咨询.
结论:
- 发作是青少年急性素过量服用的不常见但可能被低估的并发症.
- 发作可能发生在剂量低于以前在文献中报告的剂量.
- 在儿科急诊室的观察足以在没有先进的神经检查的情况下管理这些病例.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
163
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
163
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Antiepileptic Drugs: Potassium Channel Activators
191
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
191
Seizures: Classification
378
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
378
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K


